Inovio Pharmaceuticals Sees A Bounce Off Support After COVID-19 Vaccine News
Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares are trading higher Tuesday after the FDA removed a hold on the company’s late-stage COVID-19 vaccine trial in the U.S.
Inovio Pharmaceuticals is trading up 4.60% at $7.05 at market close Tuesday.
